Pharmaceutical

Ligand Pharmaceuticals to acquire APEIRON Biologics for $100m

Ligand Pharmaceuticals has announced a definitive agreement for the acquisition of APEIRON Biologics in a deal worth $100m in cash.

Jul 10, 2024 - 04:00
Ligand Pharmaceuticals to acquire APEIRON Biologics for $100m
Ligand Pharmaceuticals has announced a definitive agreement for the acquisition of APEIRON Biologics in a deal worth $100m in cash.
Read the original article

Tags:

Previous Article

Taiho exercises option for Arcus Biosciences’ quemliclustat in Asia

Next Article

Moderna and Mitsubishi Tanabe link on mRNA vaccines in Japan

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Morgan Health wants you to know it’s still here

STAT+: Morgan Health wants you to know it’s still here

Jan 10, 2024

STAT+: AI health care companies say they’ll keep humans in the loop. But what does that actually mean?

STAT+: AI health care companies say they’ll keep humans...

Mar 13, 2024

STAT+: Gilead foresees more growth in its HIV drugs

STAT+: Gilead foresees more growth in its HIV drugs

May 5, 2023